Expectant management for men with early stage prostate cancer

  title={Expectant management for men with early stage prostate cancer},
  author={Christopher P. Filson and Leonard S. Marks and Mark S. Litwin},
  journal={CA: A Cancer Journal for Clinicians},
Answer questions and earn CME/CNE 

Expectant management of veterans with early‐stage prostate cancer

The association between various factors and expectant management use among veterans diagnosed with prostate cancer is evaluated and the underused use of pregnant management has been underused.

Survival outcomes for patients with localised upper tract urothelial carcinoma managed with non‐definitive treatment

To investigate the outcomes of patients with upper tract urothelial carcinoma with non‐definitive therapy, which currently remains unknown, using a novel approach called ‘cell reprograming’.

National trends in management of localized prostate cancer: A population based analysis 2004‐2013

This work sought to better understand how the changing landscape influenced treatment utilization in the United States as national screening guidelines have been updated and diagnostic practice patterns evolved.

Radical prostatectomy versus deferred treatment for localised prostate cancer.

Assessment of effects of RP compared with deferred treatment for clinically localised prostate cancer found that radical prostatectomy versus watchful waiting RP probably reduces the risk of death from any cause and probably reducesThe risk of developing metastatic disease.

Combination Treatment Options for Castration-Resistant Prostate Cancer

Combination treatment is a strategy for treating this lethal disease and thus will be the focus of discussion in this chapter.

A prospective study of the short‐term quality‐of‐life outcomes of patients undergoing transperineal prostate biopsy

To investigate in a prospective, observational study whether transperineal prostate biopsy (TPbx) results in patient‐reported quality‐of‐life (QoL) changes from baseline in the first 3‐months after

Evolving Castration Resistance and Prostate Specific Membrane Antigen Expression: Implications for Patient Management

Simple Summary This review is a summary of recent findings on the role of prostate-specific membrane antigen (PSMA) in metastatic castration-resistant prostate cancer (mCRPC) and how they can be

The Diagnosis and Treatment of Prostate Cancer: A Review

Advances in the diagnosis and treatment of prostate cancer have improved the ability to stratify patients by risk and allowed clinicians to recommend therapy based on cancer prognosis and patient preference.

Outcomes Following Various Treatment Options for Clinically Localized Prostate Cancer

This review aimed to summarize recent literatures on surgery, radiotherapy, and expectant management, which have been the mainstays of treatment for localized prostate cancer; and introduce several treatments for the concept of focal therapy.



Outcomes of initially expectantly managed patients with low or intermediate risk screen‐detected localized prostate cancer

Study Type – Therapy (outcomes)

Early prostate cancer – which treatment do men prefer and why?

Study Type – Preference (prospective cohort)’s level of evidence’1b; andLevel of Evidence (level of evidence) 1b.

Surgical management after active surveillance for low‐risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment

Study Type – Therapy (case control)
Level of Evidence 3b

Active surveillance; a reasonable management alternative for patients with prostate cancer: the Miami experience

To examine the outcome of patients diagnosed with ‘low‐risk’ prostate cancer managed by active surveillance (AS), a large number of patients were found to be at low risk of developing prostate cancer.

Outcomes for men with clinically nonmetastatic prostate carcinoma managed with radical prostactectomy, external beam radiotherapy, or expectant management

The authors sought to define the outcomes of three common strategies for managing patients with nonmetastatic prostate carcinoma: expectant management, radiotherapy, and radical prostatectomy.

Prostate‐specific antigen velocity (PSAV) risk count improves the specificity of screening for clinically significant prostate cancer

Study Type – Prognosis (retrospective cohort analysis) – Results show clear trends in prognosis for long-term survival and disease progression in patients diagnosed with central giant cell granuloma.

Prostate cancer active surveillance and health‐related quality of life: results of the Finnish arm of the prospective trial

Study Type – Therapy (case series)

Active surveillance for prostate cancer: an Australian experience

A large cohort of Australian men who chose active surveillance as initial management of their low‐risk prostate cancer opted for active surveillance, and the patient and cancer characteristics as well as outcomes were assessed.

Short‐term outcomes of the prospective multicentre ‘Prostate Cancer Research International: Active Surveillance’ study

Study Type – Therapy (prospective cohort)
Level of Evidence 2b

Does active surveillance for men with localized prostate cancer carry psychological morbidity?

To investigate the prevalence of anxiety and depression in patients with localised prostate cancer managed by active surveillance, compared with those receiving immediate treatment, as active surveillance is a relatively new approach to managing this disease.